Akouos Reports Second Quarter 2022 Financial Results and Provides Business Highlights

15.08.2022 - Submitted IND for AK-OTOF to FDA Continued progress toward planned IND submission for AK-antiVEGF Presented new nonclinical data at ASGCT supporting the proposed clinical development of AK-OTOF and highlighting strategies for regulated gene ...

Related Keywords

United States ,Boston ,Massachusetts ,American ,Courtney Turiano ,Katie Engleman ,Exchange Commission ,Trademark Office ,Development Rd Expenses ,American Society Of Gene ,Exchange Commission On ,Drug Administration ,Company Quarterly Report On Form ,American Society ,Cell Therapy ,Annual Meeting ,Private Securities Litigation Reform Act ,Quarterly Report ,Consolidated Statements ,Stern Investor ,